Lithium Controlled-Release and Extended-Release Tablets and Naltrexone injection
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Naltrexone injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: naltrexone
Brand name: ReVia, Depade, Vivitrol
Synonyms: Naltrexone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Naltrexone Intramuscular
- Lithium Controlled-Release and Extended-Release Tablets-Naltrexone Tablets
- Lithium Controlled-Release and Extended-Release Tablets-Namenda
- Lithium Controlled-Release and Extended-Release Tablets-Namenda (Memantine Solution)
- Lithium Controlled-Release and Extended-Release Tablets-Namenda (Memantine Tablets)
- Lithium Controlled-Release and Extended-Release Tablets-Namenda XR
- Naltrexone injection-Lithium ER
- Naltrexone injection-Lithium Oral Solution
- Naltrexone injection-Lithium Salts
- Naltrexone injection-Lithium Syrup and Oral Solution
- Naltrexone injection-Lithobid
- Naltrexone injection-Lithostat